Aquilo Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Aquilo Capital Management LLC
CRD #153022
SEC #801-111633
CIK #0001591986
AUM
Employees 5 (100% Investors, 0% Brokers)
Fees
Minimum
Phone415-635-0140
AddressOne Letterman Drive
San Francisco, CA 94129
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
80064048032016002010201520212027
Fees and Compensation — Form ADV Part 2A (3/26/2024) [Brochure]
Item 5.       Fees and Compensation

 Compensation for Advisory Services – Core Fund and Offshore Fund.
 Performance Allocation and Management Fees

 Beginning February 1, 2020, the Core Fund currently offers only a limited number of Series A
 Interests to potential investors who meet the Qualified Purchasers definition under Section
 2(a)(51)(A) of the Investment Company Act of 1940. Series B and C Interests are only available to
 existing Series B and C investors that invested in the Core Fund before February 1, 2020
 (collectively, the Series A, B & C Interests are the Core Fund “Series of Interests”). Beginning
 February 1, 2020, the Offshore Fund currently only offers a limited number of Tranche A Shares
 (“Tranche Shares”) to potential investors who meet the Qualified Purchasers definition under
 Section 2(a)(51)(A) of the Investment Company Act of 1940. As investment adviser to the Core
 Fund and the Offshore Fund, Aquilo receives management fees in advance at an annual rate
 ranging from 1.5% to 1.75% (depending on the Series of Interests or Tranche Shares) of the value
 of the underlying investors' capital account balance of the Core Fund as of the first business day
 of each calendar quarter. This management fee is deducted from Core Fund assets and is prorated
 for any investment period that is less than a full calendar quarter.

 In addition to management fees, Aquilo is entitled to receive a performance allocation ranging
 from 15% to 20% (depending on the Series of Interests or Tranche Shares) of the net profits of the
 Core Fund attributable to the capital account balance of each underlying investor.

 Aquilo, at its discretion, can waive or reduce the management fee and/or the performance
 allocation for any of the investors.

 A more detailed description of the pricing structure associated with each Series of Interests and
 Tranche Shares and investor requirements is available within the Confidential Offering Circular
 for the Core Fund and the Private Offering Memorandum for the Offshore Fund.

 Compensation for Advisory Services – LO Fund and LO Offshore Fund
 Performance Allocation and Management Fees

 The LO Fund offers a limited number of offering interests (“Offering Interests”) to potential
 investors who meet the Qualified Purchasers definition under Section 2(a)(51)(A) of the
 Investment Company Act of 1940. Beginning May 1, 2020, the LO Offshore Fund offers a limited
 number of shares that are issued in different series (“Series of Shares”) to each new potential
 investor who meets the Qualified Purchasers definition under Section 2(a)(51)(A) of the
 Investment Company Act of 1940. As investment adviser to the LO Fund and the LO Offshore
 Fund, Aquilo receives in advance a quarterly management fee at an annual rate of 1.0% of the
 value of the underlying investors’ capital account balance of the LO Fund as of the first business
 day of each calendar quarter. This management fee is deducted from the LO Fund assets and is
 prorated for any investment period that is less than a full calendar quarter.

Aquilo Capital Management, LLC – ADV Part 2A                                              Page 5

 Fees Relating to Terminations and Withdrawals

 Relationships with Aquilo’s investment fund clients are terminable on the dissolution of the
 Funds or on Aquilo’s withdrawal as the general partner or adviser.

 With respect to terminating the advisory relationship, investors in the Funds generally can, on at
 least 60 days’ prior written notice, withdraw/redeem up to half of their capital account balance
 as of the end of any calendar quarter. If investors desire to withdraw/redeem their entire capital
 account balance, it will take at least 3 consecutive calendar quarters with the half limit being
 applied to the first two consecutive calendar quarters to fully withdraw/redeem that balance.
 However, if the remainder is not withdrawn/redeemed on the third consecutive calendar
 quarter, then the half withdrawal/redemption restriction again applies to the next time a
 withdrawal/redemption occurs.

 Investors in Series B and C of the Core Fund will be subject to withdrawal fees of either 3% or 5%
 for withdrawal of investments made within a specified period in accordance with each Fund’s
 documents. If an investor in any of the Funds is permitted by Aquilo to withdraw funds on a date
 other than a permitted withdrawal date, Aquilo can require the investor to pay an additional
 withdrawal fee of up to $5,000.

 The withdrawal fees described above will be deducted from the capital account balance
 otherwise payable to the withdrawing investor, will be included as income in the profits and
 losses of the other capital accounts, and can be reduced or waived by Aquilo. The withdrawal
 fees will not be charged, however, on any withdrawals relating to an amendment of the fund’s
 partnership agreement or any expulsion, or withdrawals relating to certain “key person” events.

 In all cases, investors and client accounts bear expenses, the pro rata portion of the management
 fee and the performance allocation or carried interest through the date of termination or
 withdrawal. An investment fund does not refund any management fee previously paid to an
 investor who withdraws from that fund on a date other than the last day of a quarter.

 Expenses

 Each client account is responsible for its own costs and expenses, including, but not limited to,
 trading costs and expenses (such as brokerage commissions, expenses related to short sales, and
 clearing and settlement charges), ongoing legal, accounting and bookkeeping fees and expenses,
 and the fees and expenses charged by any fund administrator for its accounting, bookkeeping,
 and other services. Aquilo generally bears its own operating, general, administrative, and
 overhead costs and expenses other than the expenses described above. Securities brokerage
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/26/2024) [Brochure]
Item 7.       Types of Clients

 Aquilo is organized and serves as the general partner and/or discretionary investment adviser to
 private investment funds. Aquilo may decide in the future to provide advice to separately
 managed accounts and to other private funds.

 Aquilo generally requires investors in the Core Fund and Offshore Fund to make a minimum initial
 investment of at least $1,000,000. Aquilo generally requires investors in the LO Fund and LO
 Offshore Fund to make a minimum initial investment of at least $5,000,000. Aquilo generally
 requires a minimum of $100,000,000 to open a separately managed account.

 The minimum contribution and investor requirements can be waived by Aquilo at its sole
 discretion.

 Investors generally must be “accredited investors” under Regulation D, who are also “Qualified
 Purchasers” under Section 2(a)(51)(A) of the Investment Company Act of 1940, as amended.
 Aquilo generally requires investors to make representations concerning their financial
 sophistication and ability to bear the risk of loss of their entire investment in a fund.

Aquilo Capital Management, LLC – ADV Part 2A                                             Page 8
Type Form D Funds Date Sold AUM
HF Aquilo Capital Special Opportunity LP [2021-03-31] 16.2 M 19.4 M
Filed 2023-08-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
Other Aquilo Capital Lo LP [2017-08-07] 212.5 M 87.6 M
Filed 2024-11-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Finder's Fee $1,344,084 · Net Assets Decline to Disclose
HF Aquilo Capital LP [2015-04-06] 257.0 M 170.0 M
Filed 2024-11-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Finder's Fee $2,091,593 · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 257.6
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 4 257.6
By Discretionary
Discretionary 4 257.6
Non-Discretionary 0 0.0
Total 4 257.6
By Non-United States Persons
Non-United States Persons 50.2
United States Persons 207.4
Total 4 257.6
Form D Directors Role # Filings # Firms 2011 - 2026
Marc Schneidman Executive Officer 4 2
Aquilo Capital Management LLC Executive Officer 3 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001591986]
3 [0001591986]
4 [0001591986]
SC 13G [0001591986]
Form 13D/13G Filer Form 13D/13G Subject Filed
Aquilo Capital Management LLC Precision Biosciences Inc [2024-03-18]
Aquilo Capital Management LLC Magenta Therapeutics Inc [2022-02-14]
Aquilo Capital Management LLC Pieris Pharmaceuticals Inc [2019-10-07]
Aquilo Capital Management LLC Synlogic Inc [2019-02-14]
Aquilo Capital Management LLC Merus NV [2019-01-03]
Aquilo Capital Management LLC Aquilo Capital Management LLC [2018-12-21]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI254900J03UBQSFDMNU40
Form 3/4/5 Subject 2011 - 2026
Aquilo Capital LP
Aquilo Capital Management LLC
Spero Therapeutics Inc
Palvella Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-09-22 Sell 1,335,512 $2.25 3,004,902
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-09-22 Sell 566,284 $2.25 1,274,139
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-04-26 Buy 39,727 $5.24 208,169
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-03-30 Buy 16,885 $8.79 148,419
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-03-30 Buy 33,115 $8.79 291,081
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-03-14 Buy 8,006 $7.63 61,086
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-03-14 Buy 15,702 $7.63 119,806
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-02-28 Buy 29,729 $9.53 283,317
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-02-28 Buy 15,104 $9.53 143,941
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-02-18 Buy 14,828 $9.24 137,011
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-01-31 Buy 125,000 $11.59 1,448,750
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-01-24 Buy 1,599 $10.89 17,413
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-01-18 Buy 48,488 $12.41 601,736
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2022-01-10 Buy 8,867 $12.93 114,650
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2021-12-31 Buy 125,000 $15.75 1,968,750
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2021-12-30 Buy 50,000 $15.77 788,500
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2021-12-29 Buy 75,493 $14.64 1,105,218
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2021-10-29 Buy 150,000 $17.53 2,629,500
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2021-09-30 Buy 134,543 $18.65 2,509,227
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
2021-09-14 Buy 2,156 $18.49 39,864
showing 20 of 41 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com